Cargando…
Elevated type I interferon-like activity in a subset of multiple sclerosis patients: molecular basis and clinical relevance
BACKGROUND: A subset of patients with multiple sclerosis (MS) shows an increased endogenous IFN-like activity before initiation of IFN-beta treatment. The molecular basis of this phenomenon and its relevance to predict individual therapy outcomes are not yet fully understood. We studied the expressi...
Autores principales: | Hundeshagen, Alexander, Hecker, Michael, Paap, Brigitte Katrin, Angerstein, Charlotte, Kandulski, Ole, Fatum, Christian, Hartmann, Christiane, Koczan, Dirk, Thiesen, Hans-Juergen, Zettl, Uwe Klaus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464734/ https://www.ncbi.nlm.nih.gov/pubmed/22727118 http://dx.doi.org/10.1186/1742-2094-9-140 |
Ejemplares similares
-
Reassessment of Blood Gene Expression Markers for the Prognosis of Relapsing-Remitting Multiple Sclerosis
por: Hecker, Michael, et al.
Publicado: (2011) -
Glatiramer acetate treatment effects on gene expression in monocytes of multiple sclerosis patients
por: Thamilarasan, Madhan, et al.
Publicado: (2013) -
Microarray data of transcriptome shifts in blood cell subsets during S1P receptor modulator therapy
por: Koczan, Dirk, et al.
Publicado: (2018) -
MicroRNA Expression Changes during Interferon-Beta Treatment in the Peripheral Blood of Multiple Sclerosis Patients
por: Hecker, Michael, et al.
Publicado: (2013) -
Multiple Sclerosis: Modulation of Toll-Like Receptor (TLR) Expression by Interferon-β Includes Upregulation of TLR7 in Plasmacytoid Dendritic Cells
por: Derkow, Katja, et al.
Publicado: (2013)